King & Wood Mallesons, Healthcare (PRC Firms) | Chambers Greater China Region Profile

About

Provided by King & Wood Mallesons

Effective advice built on strong foundations

Healthcare and pharmaceutical companies come to us not only because we have deep expertise and the best people, but also because we bring industry knowledge to our practice.

With technological advances, ever-changing government regulations, and strict ethical considerations, it is clear that understanding legislation in the healthcare industry is no simple matter. We therefore seek to base our legal advice on a comprehensive understanding of today's industry developments. We keep abreast of legal and commercial developments in the pharmaceutical industry and host seminars for our clients to stay on the cutting edge of the industry together.

We provide legal advice to clients in the pharmaceutical and healthcare industries in areas such as intellectual property, regulation, business, competition and corporate law. With strong support from our offices throughout China and Australia, our clients can benefit from our local expertise where need it most. We know that sometimes clients need to close a deal or respond to a question quickly, so we focus on making sure the clients get straight and clear answers quickly.

Chambers Review

Provided by Chambers

Healthcare (PRC Firms) - China

Band 2

What the Team is Known For

King & Wood Mallesons has a prominent healthcare and pharmaceuticals team which advises an impressive client base of international and local investors in the industry. The team is highly experienced in handling corporate, investment, capital market and IP matters as well as regulatory and licensing matters, and is especially skilled in cross-border transactions. It acts for clients from sectors including pharmaceuticals, biotechnology, health insurance and medical service providers. The firm offers expertise in contentious matters in the healthcare space, notably in relation to IP infringements and corporate investigation issues.

业务优势

金杜律师事务所拥有一支杰出的医疗保健和制药团队，在医疗领域里持续为令人刮目相看的国际和本地投资者客户群提供建议。该团队处理公司、投资、资本市场、知识产权及合规事宜经验丰富，尤其擅长处理跨境交易。其代表各行业客户，包括制药、生物技术、医疗保险和医疗服务供应商。金杜就医事法领域内的争议性事务提供专业知识，特别是有关知识产权侵权和公司调查的案件。

View ranking table

Work Highlights

Provided by King & Wood Mallesons

King & Wood Mallesons represented Novo Nordisk in an administrative lawsuit in the Beijing IP Court against the State Intellectual Property Office's decision to invalidate the client's patent on semaglutide, a blockbuster drug for Type 2 diabetes. The case resulted in the invalidation being revoked after the third trail.
金杜律师事务所代理诺和诺德在北京知识产权法院就国家知识产权局宣布其2型糖尿病药物司美格鲁肽专利无效一案提起行政诉讼，该无效决定在第三次庭审后被撤销。

Strengths

Provided by Chambers

KWM is long-standing in the pharmaceutical area. They are experienced and have the reputation. Their lawyers are very good and easy to work with.